PTEN and p53 tumor suppressors are often given co-status as ‘the guardians of the genome’, because both are transcription factors that activate complex programs of apoptosis in cells that suffer potentially tumorigenic levels of DNA damage (Yin & Shen 2008, Ryan 2011). This evidence concerns the gene PTEN and neoplasm.